Differences in Uni-dimensional Breathlessness Measures and Thresholds for Clinical Response in a Randomised Controlled Trial in People with Chronic Breathlessness: an Exploratory Study

Overview

Journal BMJ Open Respir Res

Date 2024 Dec 4

PMID 39632100

Authors

Diana Ferreira

Magnus Ekstrom

Sandra Louw

Philip McCloud

Miriam Johnson

Katherine Clark

David Currow

Affiliations

Soon will be listed here.

Abstract

Introduction: Optimally measuring improvements in chronic breathlessness in clinical practice and research continues to evolve. The aim of this study was to consider the performance of uni-dimensional measures in .

Methods: We report five measures of breathlessness (intensity: and in the previous 24 hours; ; and an affective component ) and two clinical thresholds over baseline on their 0-100 mm visual analogue scale (8.9 mm absolute improvement; and 15% relative improvement) collected in a multi-site, randomised, double-blind, parallel-arm, placebo-controlled trial of regular, low-dose, sustained-release morphine for people with with optimally treated underlying causes.

Results: Participants (n=284) were mostly elderly men with severe, chronic breathlessness. showed improvement in people with more severe breathlessness and chronic obstructive pulmonary disease. By contrast, and generated similar patterns of response, as did and sness added little value. The two clinical thresholds showed differing patterns of significance.

Discussion: Consistent with other recent work, worst breathlessness may be an important uni-dimensional outcome in evaluating chronic breathlessness clinically and in research. This study does not support a differential between unpleasantness now and breathlessness now, previously observed in laboratory-generated, acute-on-chronic breathlessness. Timeframe for recall (now or the last 24 hours) and the threshold for a clinical meaningful improvement (absolute (8.9 mm) or relative (15%)) affect assessment performance.

References

Kochovska S, Chang S, Morgan D, Ferreira D, Sidhu M, Moussa R . Activities Forgone because of Chronic Breathlessness: A Cross-Sectional Population Prevalence Study. Palliat Med Rep. 2021; 1(1):166-170. PMC: 8241375. DOI: 10.1089/pmr.2020.0083. View

Currow D, Chang S, Ekstrom M, Hutchinson A, Luckett T, Kochovska S . Health service utilisation associated with chronic breathlessness: random population sample. ERJ Open Res. 2021; 7(4). PMC: 8503326. DOI: 10.1183/23120541.00415-2021. View

von Leupoldt A, Bradley M, Lang P, Davenport P . Neural processing of respiratory sensations when breathing becomes more difficult and unpleasant. Front Physiol. 2011; 1:144. PMC: 3059926. DOI: 10.3389/fphys.2010.00144. View

Currow D, Chang S, Reddel H, Kochovska S, Ferreira D, Kinchin I . Breathlessness, Anxiety, Depression, and Function-The BAD-F Study: A Cross-Sectional and Population Prevalence Study in Adults. J Pain Symptom Manage. 2019; 59(2):197-205.e2. DOI: 10.1016/j.jpainsymman.2019.09.021. View

Kochovska S, Ferreira D, Chang S, Brunelli V, Morgan D, Similowski T . Disability and long-term breathlessness: a cross-sectional, population study. BMJ Open Respir Res. 2024; 11(1). PMC: 11268077. DOI: 10.1136/bmjresp-2023-002029. View

Schaeffer M, Mendonca C, LeVangie M, Andersen R, Taivassalo T, Jensen D . Physiological mechanisms of sex differences in exertional dyspnoea: role of neural respiratory motor drive. Exp Physiol. 2013; 99(2):427-41. DOI: 10.1113/expphysiol.2013.074880. View

Kochovska S, Chang S, Ferreira D, Brunelli V, Luckett T, Morgan L . Invisibility of breathlessness in clinical consultations: a cross-sectional, national online survey. Eur Respir J. 2022; 60(5). DOI: 10.1183/13993003.01603-2022. View

Lovell N, Etkind S, Bajwah S, Maddocks M, Higginson I . To What Extent Do the NRS and CRQ Capture Change in Patients' Experience of Breathlessness in Advanced Disease? Findings From a Mixed-Methods Double-Blind Randomized Feasibility Trial. J Pain Symptom Manage. 2019; 58(3):369-381.e7. DOI: 10.1016/j.jpainsymman.2019.06.004. View

Hanania N, ODonnell D . Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions. Int J Chron Obstruct Pulmon Dis. 2019; 14:1127-1138. PMC: 6538882. DOI: 10.2147/COPD.S188141. View

10.

Kochovska S, Chang S, Olsson M, Ekstrom M, Currow D . Associations in Perceived Health and Persistent Breathlessness: A Cross-Sectional Study. Palliat Med Rep. 2023; 4(1):120-126. PMC: 10122221. DOI: 10.1089/pmr.2022.0071. View

11.

Currow D, Chang S, Grande E, Ferreira D, Kochovska S, Kinchin I . Quality of Life Changes With Duration of Chronic Breathlessness: A Random Sample of Community-Dwelling People. J Pain Symptom Manage. 2020; 60(4):818-827.e4. DOI: 10.1016/j.jpainsymman.2020.05.015. View

12.

Kochovska S, Currow D, Chang S, Johnson M, Ferreira D, Morgan D . Persisting breathlessness and activities reduced or ceased: a population study in older men. BMJ Open Respir Res. 2022; 9(1). PMC: 9125752. DOI: 10.1136/bmjresp-2021-001168. View

13.

Ekstrom M, Johnson M, Huang C, Currow D . Minimal clinically important differences in average, best, worst and current intensity and unpleasantness of chronic breathlessness. Eur Respir J. 2020; 56(2). DOI: 10.1183/13993003.02202-2019. View

14.

Olsson M, Bjorkelund A, Sandberg J, Blomberg A, Borjesson M, Currow D . Factors most strongly associated with breathlessness in a population aged 50-64 years. ERJ Open Res. 2024; 10(2). PMC: 10962452. DOI: 10.1183/23120541.00582-2023. View

15.

Johnson M, Bland J, Oxberry S, Abernethy A, Currow D . Clinically important differences in the intensity of chronic refractory breathlessness. J Pain Symptom Manage. 2013; 46(6):957-63. DOI: 10.1016/j.jpainsymman.2013.01.011. View

16.

Johnson M, Bland J, Oxberry S, Abernethy A, Currow D . Measuring improvement in dyspnoea: should absolute or relative values be used?. Eur Respir J. 2014; 44(6):1700-3. DOI: 10.1183/09031936.00108014. View

17.

Nishimura K, Izumi T, Tsukino M, Oga T . Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002; 121(5):1434-40. DOI: 10.1378/chest.121.5.1434. View

18.

Ferreira D, Ekstrom M, Sajkov D, Vandersman Z, Eckert D, Currow D . Extended-Release Morphine for Chronic Breathlessness in Pulmonary Arterial Hypertension-A Randomized, Double-Blind, Placebo-Controlled, Crossover Study. J Pain Symptom Manage. 2018; 56(4):483-492. DOI: 10.1016/j.jpainsymman.2018.07.010. View

19.

Moher D, Hopewell S, Schulz K, Montori V, Gotzsche P, Devereaux P . CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010; 340:c869. PMC: 2844943. DOI: 10.1136/bmj.c869. View

20.

Ahmadi Z, Sandberg J, Shannon-Honson A, Vandersman Z, Currow D, Ekstrom M . Is chronic breathlessness less recognised and treated compared with chronic pain? A case-based randomised controlled trial. Eur Respir J. 2018; 52(3). PMC: 6340635. DOI: 10.1183/13993003.00887-2018. View